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ABSTRACT
Palliative and end of life care is essential to
healthcare systems worldwide, yet a minute
proportion of research funding is spent on
palliative and end of life care research.
Routinely collected health and social care data
provide an efficient and useful opportunity for
evaluating and improving care for patients and
families. There are excellent examples of
routine data research in palliative and end of
life care, but routine data resources are widely
underutilised. We held four workshops on
using routinely collected health and social care
data in palliative and end of life care.
Researchers presented studies from the UK,
USA and Europe. The aim was to highlight
valuable examples of work with routine data
including work with death registries, hospital
activity records, primary care data and specialist
palliative care registers. This article disseminates
that work, describes the benefits of routine
data research and identifies major challenges
for the future use of routine data, including;
access to data, improving data linkage, and the
need for more palliative and end of life care
specific data.
BACKGROUND
The palliative care resolution adopted by
the WHO in 2014 recognises palliative
and end of life care (PEoLC) services as
essential and integral to health systems
worldwide.1 However, evidence for
effective models of care is limited, not
least by current low levels of spending on
PEoLC research; 0.24% of cancer
research funding is currently spent on
PEoLC research.2 Routinely collected
health data provides a useful opportunity
for evaluating and improving care for
patients and families. In December 2013
and March 2014 we held a series of
workshops to showcase routine data
research in PEoLC, highlight examples of
best practice, and stimulate discussion
about the potential future use of these
resources.
The events were hosted by the
National End of Life Care Intelligence
Network (NEoLCIN), part of Public
Health England (PHE), in partnership
with the Cicely Saunders Institute (CSI)
at King’s College London. One hundred
and twenty-five delegates attended the
workshops, including researchers from
the UK and internationally, representa-
tives from data holding bodies, govern-
ment organisations, charities,
practitioners and experts by experience
(also known as service users). The aim of
this paper is to describe the current use
and the benefits of routine data analysis
in PEoLC. The main focus of this paper
is on English data, though case studies
from Europe and the USA which were
presented at the workshops are included
to highlight the use of routine data ana-
lysis in other healthcare systems. Based
on the discussions from workshops, three
future priorities are identified for the use
of routine data in PEoLC.
WHAT IS ROUTINE DATA?
Routine data are generated by administra-
tive and clinical processes as opposed to
data generated solely for the purposes of
research. Death registry data, primary
and secondary care data, and other rou-
tinely collected health data are increas-
ingly used in PEoLC research. The
inherent value of routine data is that it
already exists and often on a population
basis, negating the challenges associated
with primary data collection in PEoLC.
Each resource has particular strengths
and weaknesses in the context of second-
ary use in PEoLC research.
The level (person, service or area), or
unit that data are collected and made avail-
able at has consequences for how the data
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can be used and how it is governed (figure 1). The pro-
portion of home deaths in a region (area level data), or
number of specialist palliative care (SPC) consultants
based at a hospital (service level data), allow compari-
sons to be made between areas and services. Person level
data contain the richest information about patient’s
characteristics, their diagnosis and treatments. A com-
bination of area, service and person level data are
needed to fully understand healthcare. Patient centred
outcome measures (PCOMs), are increasingly seen as
the gold standard for measuring quality of care, and
require person level data collected uniformly over time.
Death registry data
Death registry data are an important source of routine
data for PEoLC and has been successfully used to draw
attention to temporal, spatial and patient variation in
place of death.3 4 In most countries a legal requirement
to register all deaths means that death registries have
complete population coverage. Furthermore, the rela-
tive simplicity and consistency of the information col-
lected in death registries, and adherence to
international WHO standards on recording causes of
death, makes death registry data well suited to histor-
ical and international comparisons Box 1.
Place of death has been widely used as a proxy for
quality of care. However, there are limitations to what
we can learn from the fairly shallow set of cross-
sectional data contained in death registries. There is
now a call to broaden the focus, to measure treat-
ments, preferences, and quality of care directly, to do
this we must use different data.
Hospital activity data
Data collected in hospitals are our main source of infor-
mation on the diagnosis and treatment received by
patients in secondary and tertiary care settings. In
England the national hospital activity data set, Hospital
Episode Statistics (HES), is beginning to be used in
PEoLC studies.6 Other national resources on secondary
and tertiary care include Cancer Registry data, and the
Mental Health and Learning Disabilities data.
Routine data, if sufficiently detailed, can lend itself
to use with quasi-experimental methods such as pro-
pensity score matching, difference-in-differences, pre-
dictive risk modelling, causal networks, and
instrumental variable analysis. These methods seek to
generate robust evidence on the effects of interven-
tions and treatments, and are particularly useful for
building evidence on populations who might be diffi-
cult to include in clinical trials such as those in the
last days of life, the very frail or cognitively impaired.
Box 2 uses American hospital data generated for
insurance claims with propensity score matching. The
propensity score matching method is a retrospective
matching exercise that comprehensively matches a
control group to a treatment group alike on all
measured characteristics other than the receipt of the
treatment or exposure.
Primary care data
In the UK, general practitioners (GPs) working in
primary care are often the first point of contact for
patients and around 90% of the UK population is
registered with a GP. Plans to make GP data available
nationally in England via the National Health Service
(NHS) ‘care.data’ resource are on hold after confi-
dence in the project was undermined by concerns
about privacy of data. The Clinical Practice Research
Datalink (CPRD)—previously the General Practice
Research Database (GPRD)—is currently the largest
available collection of primary care data, containing
longitudinal medical records on a sample of around
10% of the UK population. A recent study using the
GPRD confirmed the increasing trend of single and
multiple opioid prescribing for patients with cancer at
the end of life and highlighted underprescription of
opioids to older people.8
Other European countries face similar challenges
generating accessible, national primary care data. The
European Sentinel GP Networks Monitoring End of
Life Care (EURO SENTIMELC) project addresses this
by collecting data from a representative network of
GPs from four countries; Belgium, the Netherlands,
Italy and Spain, covering 2%–4% of the general popu-
lation in each country.9 Participating GPs register all
deaths on a weekly basis, using a standardised form,
generating an epidemiological ‘surveillance system’
used to compare and monitor end of life care across
countries and over time.
Locally available data
Another major gap in the available national data is the
lack of data on social care. Here locally collected data
have provided valuable insight. The Nuffield Trust, in
collaboration with the NEoLCIN, used data on state-
funded community social care from seven local
authorities (LA) in England, and linked it at individual
level to secondary healthcare data. The project investi-
gated the association between health and social care
use in the past 12 months of life, showing wide vari-
ation between LAs, and indicated an inverse relation-
ship between social care use and hospital use at the
end of life.10
National surveys and service monitoring data
The NHS carries out surveys on large nationally rep-
resentative samples to monitor service users’ experi-
ence of care. These surveys are not routine data, but
are regularly collected and can be used to examine
variation between groups and evaluate policy. For
example, a recent study using data from the Views of
Informal Carers—Evaluation of Service (VOICES)
survey, a mortality follow-back survey, demonstrated
that relatives of people aged 85 years and over are less
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likely than those of younger people to know their
loved one’s preferences for end of life care, and that
this significantly contributes to age-related disparity in
place of death.11
Much of the monitoring data collected by the NHS,
including VOICES and other surveys such as the
Carers Survey and the Adult Social Care Survey is
publically available, at area level, providing useful
sources of open access ecological data (http://www.
hscic.gov.uk/searchcatalogue). The NEoLCIN also
provides area level data, available to download from
their website (http://www.endoflifecare-intelligence.
org.uk/end_of_life_care_profiles/), and periodically
updates interactive area profiles covering key indica-
tors including place of death. Another useful source
of open access aggregate data is the UK Data Service
(http://ukdataservice.ac.uk/), a gateway for researchers
wanting to access Census derived data, administrative
data from social services, education, tax, and social
security systems and large health and social survey
data. Despite a drive towards more open access, data
available in the public domain are usually not pro-
vided at individual level.
Methodological challenges
A challenge for using routine data in research is the
varying quality of the data. For example, English death
registry data contain no information about ethnicity
and poor quality occupation-based social class data,
limiting its usefulness for understanding sociodemo-
graphic variability in place of death.12 Changes in clas-
sification and coding practices, such as the
introduction in 1993 of ‘hospice’ as a separate place of
death category, and the switch in 2001 to International
Figure 1 Different units of routinely collected data.
Box 1 Place of death of older persons with dementia: a study in five European Countries5
Aim: To compare where people with dementia died across five European countries; Belgium, the Netherlands, England, Wales and Scotland
Methods: Death registry data on all deaths in 2003 of people aged 65 and older were obtained for the five countries, and then linked to area-level data
on the number of hospital beds and nursing home beds per 1000 of the population aged over 65
Results: Home death was rare (3–5%) apart from in Belgium (11%). Death in hospital was higher in the UK (England 36.0%; Wales 46.3%; Scotland
33.9%) and Belgium (22.7%). In all countries the majority of dementia patients died in long-term care facilities. The Netherlands had the lowest rate of
hospital deaths (2.8%) and the highest rate of nursing home deaths (92.3%)
Belgium The Netherlands England Wales Scotland Total
Health resource Hospital beds/1000 5.57 3.67 3.05 3.95 4.62 3.52
Nursing home beds/1000 4.54 10.75 8.37 4.18 7.82 8.24
Place of death % Home 11.4 3.8 3.7 3.2 5.0 4.5
Hospital 22.7 2.8 36.0 46.3 33.9 27.4
Nursing home 65.9 92.3 59.7 50.2 60.8 67.5
Hospice or other SPC 0.0 0.5 0.3 0.1 0.4 0.3
Implications of this research: The study suggests that the Dutch model of nursing home provision, characterised by good availability of long-term care
facilities with specialist nursing and physician care, could be advantageous for reducing hospital deaths in dementia patients
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Classifications of Disease, 10th Version (ICD-10),
from ICD-9, affects comparability of data over time.
Another consideration should be bias in the inclusion
or exclusion of particular groups or events from data
sets. For example, US Medicare insurance data are
largely limited to a population aged over 65 years.
Routine data are prone to problems with inaccurate
or inadequate measurement of the issues of interest to
researchers, due to the fact that researchers usually
have no control over what data are collected or how.
This can mean that routine data lack the components
to make robust conclusions and adequately control for
confounding factors, or chance variability.13 14 The
REpoting of studies Conducted using Observational
Routinely collected Data (RECORD) are a useful
resource for ensuring quality and transparency in
reporting routine data research.15
FUTURE PRIORITIES
Discussion in our workshops identified three major
challenges for the use of routine data in PEoLC
research: safe and ethical access to data, improving
data linkage, and the need for more PEoLC specific
data.
Safe and ethical access to data
There is an on-going debate regarding national health
and social data; on the one hand recognition of the
power of data to inform better care, and on the other
heightened concern about misuse of data and risks to
personal privacy. Lack of clarity over the safe and
ethical secondary use of data is arguably the biggest
barrier preventing better access to routine data for
research. In general accessing health and social care
data for research purposes in England is a difficult,
lengthy and uncertain process. However, there are
systems that buck this trend; the Clinical Record
Interactive Search (CRIS), based at the National
Institute for Health Research (NIHR) Biomedical
Research Centre and Dementia Unit (BRC/U), is one
example of a system that has been specifically
designed to facilitate research access to individual
level clinical data, demonstrating that safe and effi-
cient secondary use of data is possible.16 The CRIS
also uses natural language processing, enabling ana-
lysis of free-text patient notes, beyond the scope of
traditional data analysis.
Improved data linkage
Linking data sets is the primary way we can use data
more effectively. However, linked data also carries the
most risks in terms of potential identifiability and sen-
sitivity of data. In recent years in England there has
been a concerted effort via the introduction of trusted
third parties (TTP) and the Administrative Data
Research Network (ADRN) (previously the
Administrative Data Liaison Service (ADLS)) to
improve access to linked data (http://adrn.ac.uk/).
There are also developments in technology that can
aid safe data linking; DataSHIELD is one approach in
development that allows remote data pooling.17
Another approach is the use of shared pseudonymisa-
tion ‘keys’ to enable multiple data holders to protect
the identity of individuals before sharing the data in a
linkable form.10 The best examples of cross-sectorial
data linkage come from Nordic countries.18 Key fea-
tures of the Nordic systems are the widespread use of
shared unique identifiers, strong collaboration
between data holding bodies, an established legal basis
for the collection and use of data, and broad public
approval for the use of linked administrative data.
PEoLC specific data
Population registers collecting data on all patients
receiving SPC currently exist in Denmark and
Sweden. Plans for a new national, patient level, data
Box 2 Does feeding tube insertion and its timing
improve survival?7
Aim: To test the association between insertion of a
feeding tube (FT), and timing of the insertion, with sur-
vival in patients with advanced cognitive impairment.
Methods: Data on 36 492 nursing home residents with
dementia was obtained from the US national mandatory
Minimum Data Set for Nursing Homes (MDS-NH), and
linked to Medicare health insurance claims data. The
data set covered the period 1999–2007.
Propensity score matching was used to match those with
a FT (treatment group) to those without a FT (control
group) based on sociodemographic variables; evidence of
advance care planning including advance directives,
do-not-resuscitate orders, do not-hospitalise orders, and
any feeding restrictions; pertinent medical diagnoses
from the MDS; clinical conditions including dehydration,
inability to consume food or fluids, fever, wound infec-
tion, weight loss, swallowing problems, chewing pro-
blems, syringe feeding, mechanically altered diet, dietary
supplementation, the amount of body fat as measured
according to body mass index, and presence of a pres-
sure ulcer; measures of functional status and disease
severity including activity of daily living score; and two
models that predict mortality (Advanced Dementia
Prognostic Tool score18 and Changes in Health,
End-stage disease and Symptoms and Signs score).
One year survival was compared for the treatment and
control groups. For those with a FT, 1 year survival was
compared for four cohorts based on the timing of
insertion.
Results: 1957 (5.4%) residents had a FT inserted. No dif-
ference in survival was found between those with and
those without a FT. For those with a FT, the timing of
insertion was also not associated with survival.
Implications of this research: The study provides strong
evidence for the ineffectiveness of this highly invasive
treatment in this population.
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collection from SPC services in England are currently
underway.19 The data will include elements from the
Integrated Palliative care Outcome Scale (IPOS), a
PCOM developed and validated for use with dying
patients. This represents a major step forward in our
ability to evaluate quality of PEoLC in England.
Two other international SPC data collections are
notable; the Australian Palliative Care Outcomes
Collaborative (PCOC),20 and the Coalition of
Hospices Organised to Investigate Effectiveness
(CHOICE) in the USA.21 An important feature of
PCOC and CHOICE is the involvement of health-
care professionals in agreeing the common set of
measures to collect and how the data should be
used, including strong systems of feeding back the
data to services.
We should be mindful that not all patients who
could benefit from SPC will receive SPC, and these
patients would be excluded from an SPC register.
Access to a broad range of data is necessary to under-
stand the PEoLC needs of the whole population.
Quality concerns about existing non-PEoLC specific
routine data are pertinent problems. For example the
underreporting of specialist palliative care activity in
hospital activity data. Where there are quality-related
limitations to using existing routine data in PEoLC,
surely it is our responsibility to report these fully and
identify solutions for improving the data.
NEXT STEPS: PRIORITIES FOR THE BETTER
UTILISATION OF ROUTINE DATA IN PEOLC
The following six points were identified during the
workshops as priorities for progressing work with
routine data in PEoLC.
Safe and ethical access to data:
1. Strengthen collaborative relationships with data holding
bodies; invite representatives to join project advisory
groups and attend conferences;
2. Encourage data holding bodies to publish a portfolio of
existing projects accessing their data. This could aid
transparency, help to avoid repetition and wastage in
research, and encourage collaboration across teams and
disciplines.
Improved data linkage:
3. Build expertise within PEoLC about safe data linkage
techniques that enable more innovative linkage projects;
4. Pursue new and different data sets for linking projects,
including locally collected data.
PEoLC specific data:
5. Take responsibility for highlighting limitations of current
routine data resources and suggest ways in which these
problems might be overcome.
6. Engage with the wider PEoLC community—healthcare
professionals, service planners, patients and families—
with the potential benefits routine data can have for
improving care. Better engagement can help to improve
the quality of existing data collections, and help to
inform the development of new resources, and the gov-
ernance of routine health data.
CONCLUSIONS
The routine data workshop series benefited from
involvement of international colleagues. Nevertheless, a
limitation of the work is the predominant focus on
English data. An overarching theme has been the benefits
we can glean from engagement beyond our immediate
colleagues. We hope that the series has been successful in
building relationships that will further work with
routine data in PEoLC. Above all there is a clear impetus
and enthusiasm for increasingly using routine data
resources to improve care for patients and families.
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